Dhaval Desai

Dhaval Desai

Företagsledare/Principal på 4D MOLECULAR THERAPEUTICS, INC.
Health Technology
Consumer Services
Commercial Services

Profil

Dhaval Desai currently works at 4D Molecular Therapeutics, Inc., as Chief Development Officer from 2024.
Dr. Desai also formerly worked at Thrombogenics, Inc., as Global Director-Medical Affairs from 2011 to 2014, Aerpio Therapeutics, Inc., as Vice President-Medical Affairs, Novartis AG, as Vice President & Head-US Ophthalmics from 2018 to 2020, Aerpio Pharmaceuticals, Inc., as Chief Strategy Officer & VP-Medical Affairs from 2014 to 2018, and IVERIC bio, Inc., as Chief of Staff from 2020 to 2021.
Dr. Desai received his doctorate degree from Rutgers State University of New Jersey.

Aktiva positioner av Dhaval Desai

FöretagPositionStart
4D MOLECULAR THERAPEUTICS, INC. Företagsledare/Principal 2024-09-25

Tidigare kända positioner av Dhaval Desai

FöretagPositionSlut
NOVARTIS AG Företagsledare/Principal 2020-08-01
AERPIO PHARMACEUTICALS Teknisk/Vetenskaplig/F&U Direktör -
Företagsledare/Principal 2014-07-01
IVERIC BIO, INC. Personalchef 2021-04-01
Teknisk/Vetenskaplig/F&U Direktör -
Se detaljerna i Dhaval Desais erfarenhet

Dhaval Desais utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

15

Första gradens relationer

7

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag7

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Börsen
  2. Insiders
  3. Dhaval Desai